COGI GYNECOLOGY

GYNECOLOGY

08:30-10:00	HRT AND CANCER	HALL B
Capsule	Demystification of the relationship between HRT and cancer
Chairpersons	Santiago Palacios, Spain Sven O. Skouby, Denmark
08:30-09:00	Can HRT and treatment for menopause be individualized to reduce the incidence of breast cancer? Mark Brincat, Malta
09:00-09:30	Breast cancer in special populations Herjan Coelingh Bennink, Netherlands
09:30-10:00	HRT in cancer survivors Pierluigi Benedetti Panici, Italy

10:00-10:20

Coffee break, poster viewing and visit the exhibition

Exhibition Area

10:20-11:50

INDUSTRY SUPPORTED SESSION

HALL B

11:50-12:10

Break

12:10-13:40	VULVAR AND VAGINA	HALL B
Capsule	Longevity accentuates the need for better strategies for vulvar and vaginal atrophy
Chairperson	Nick Panay, UK Sven O. Skouby, Denmark
12:10-12:30	Advances in anatomy and physiology of the vagina based on new treatments Santiago Palacios, Spain
12:30-12:50	Vulvar pains and co-morbidities: Data from 1183 cases Alessandra Graziottin, Italy
Capsule	Postmenopausal atrophy of the lower genital and urinary tract is distressing and requires new ideas to control symptoms
12:50-13:20 12:50 13:00 13:10	Debate: Is laser effective for treatment of Stress Urinary Incontinence (SUI) Yes: Zdenko Vizintin, Slovenia No: Tim Hillard, UK Discussion
13:20-13:40	Translational medicine in reproductive ageing Sven O. Skouby, Denmark

13:40-14:30

Lunch break, poster viewing and visit the exhibition

Exhibition Area

14:30-16:30	PRESCRIBING HRT	HALL B
Capsule	Balancing the benefits/risks of HRT will allow larger populations to enjoy HRT
Chairpersons	Mark Brincat, Malta Alessandra Graziottin, Italy
Capsule	The controversy surrounding androgen addition to HRT is ongoing
14:30-15:00	Should androgens be routinely offered to optimize quality of life in menopause? Alessandra Graziottin, Italy
15:00-15:30	Update on practical prescribing of new hormone therapy regimens Nick Panay, UK
15:30-16:00	New strategies in the prevention of fragility fractures Santiago Palacios, Spain
16:00-16:30	Use of HRT for cardiovascular prevention Johannes Ott, Austria

16:30-16:50

Coffee break, poster viewing and visit the exhibition

Exhibition Area

16:50-18:20	GLOBAL HEALTH INITIATIVES IN GYNECOLOGICAL MALIGNANCIES	HALL B
Capsule	In 90 minutes around the world
Chairpersons	Sara Nasser, Germany Jalid Sehouli, Germany
16:50-16:55	Greetings and Introduction
1655-17:05	A wake-up call: Gynecological oncology on the global health agenda Andreas Ullrich, Switzerland
17:05-17:15	20 years of gynaecological capacity building in Cameroon through partnership Patrick Petignant, Switzerland
17:15-1720	Q & A
17:20-17:30	Digital health as a driver for global women’s health: The iSTARC and PARSGO Vision Sara Nasser, Germany
17:30-17:40	Patient advocacy groups in the MENA Region Joelle Abou Khalil, Lebanon-Sweden
17:40-17:50	Q & A
17:50-18:00	Towards a global women’s health taskforce Jalid Sehouli, Germany
18:00-18:20	Panel Discussion: Namory Keita, Guinea Basel Refky, Egypt Hind ElMalik, Qatar

08:30-10:00	ENDOMETRIAL CANCER	HALL B
Capsule	News, options and current barriers in the management of endometrial cancer
Chairpersons	Robert Armbrust, Germany Jalid Sehouli, Germany
08:30-09:00	Clinical implications of molecular diagnostics in endometrial cancer Elena Braicu, Germany
09:00-09:30	Personalized surgical approach in endometrial cancer Robert Armbrust, Germany
09:30-10:00	New options in medical therapy of advanced and relapsed endometrial cancer Jalid Sehouli, Germany

10:00-10:20

Coffee break, poster viewing and visit the exhibition

Exhibition Area

10:20-11:50	WOMEN’S HEALTH AND WEALTH A PREIS SCHOOL ACADEMY SESSION	HALL B
Chairpersons	Gian Carlo Di Renzo, Italy Nick Panay,UK
10:20-10:25	Welcome Gian Carlo Di Renzo, Italy
10:25-10:35	The Welfare of Women (WoW) global health program endorsed by FIGO Gian Carlo Di Renzo, Italy
10:35-10:50	Will body-identical MHT become the first choice for menopausal hormone therapy? Vanadin Seifert-Klauss, Germany
10:50-11:05	Testosterone or not testosterone in menopause: That’s the question! Nick Panay, UK
11:05-11:20	Which progestogen to optimize breast and endometrial safety in MHT? Ewald Boschitsch, Austria
11:20-11:50	Q & A

11:50-12:00

Break

12:00-13:30	IN SEARCH OF NEW PERSPECTIVES: POI MAINLY DRIVEN BY GENETICS	HALL B
Capsule	Can better understanding lead to better solutions?
Chairpersons	Bart Fauser, Netherlands Nick Panay, UK
12:00-12:25	Is the ovary the mirror of longevity? Micheline Misrahi, France
12:25-12:45	Genetic architecture of reproductive ageing Felix Day, UK
12:45-13:05	FMR1 and the genetic control of folliculogenesis Julia Rehnitz, Germany
13:05-13:30	Endo-ERN and POI Luca Persani, Italy

13:30-14:20

Lunch break, poster viewing and visit the exhibition

Exhibition Area

14:20-15:50	SLS: THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS	HALL B
Capsule	Surgical management of endometriosis depends on thorough understanding of the pathophysiology and anatomy
Chairpersons	Jessica Ybanez Morano, USA Mona Orady, USA
14:20-14:50	VNOTES: Vaginal Natural Orifice Transluminal Endoscopic Surgery Jessica Ybanez Morano, USA
14:50-15:20	Pearls in endometrioma management Mona Orady, USA
15:20-15:50	Robotics: A systematic approach to deep infiltrative endometriosis Thiers Soares Raymundo, Brazil

15:50-16:00

Break

16:00-17:00

INDUSTRY SUPPORTED SESSION

HALL B